German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US ...

Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...

Today’s White House MAHA Commission report is expected to pull punches on pesticide regulation as Bayer lobbies to limit ...

President Donald Trump should block the U.S. House from limiting the regulation of pesticides and "forever chemicals" in its ...

The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...

Life Couriers wants to store and distribute medications used to treat prostate cancer and leukemia from a warehouse along ...

Whatever was behind Long’s removal, the administration is crossing into dangerous new territory in trying to pry open private ...

These microscopic plastic bits are so small that you can’t see, feel or taste them. They can embed deep in our lungs and can ...